SIS
CPRX

Sound Income Strategies’s Catalyst Pharmaceutical CPRX Stock Holding History

Sound Income Strategies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-597
Closed -$14.8K – 866
2026
Q1 		$14.8K Buy
597
+291
+95% +$6.93K ﹤0.01% 1322
2025
Q4 		$6.95K Buy
+306
New +$6.82K ﹤0.01% 1667
2025
Q2 		– Sell
-2,654
Closed -$64.4K – 1630
2025
Q1 		$64.4K Buy
+2,654
New +$59.8K ﹤0.01% 458

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CNAM
Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return

Sound Income Strategies's CPRX Position: Q2 2026 in Review

Sound Income Strategies sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 597 shares — an estimated $14.8K sold.

Sound Income Strategies first reported a position in CPRX in Q1 2025 and held it in 3 quarters. The position peaked at $64.4K in Q1 2025. 106 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Sound Income Strategies reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 597 Catalyst Pharmaceutical shares in Q2 2026, an estimated $14.8K.
  • Sound Income Strategies first reported a position in Catalyst Pharmaceutical in Q1 2025 and held it in 3 quarters.
  • Sound Income Strategies's Catalyst Pharmaceutical position peaked at $64.4K in Q1 2025.
  • 106 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.